Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration-Resistant Prostate Cancer Treatment with Eribulin
J. G C Van Hasselt*, A. Gupta, Z. Hussein, J. H. Beijnen, J. H M Schellens, A. D. R. Huitema
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration-Resistant Prostate Cancer Treatment with Eribulin'. Together they form a unique fingerprint.